Otsuka Pharmaceuti1xbet 한국l Co., Ltd.
Nutraceuti1xbet 한국ls
July 9, 2021
Pharmavite, a U.S. subsidiary of Otsuka Pharmaceutical, acquires Uqora, a provider of women's urinary tract 1xbet 한국alth products
Pharmavite, LLC, a California-based subsidiary of Otsuka Pharmaceutical Co., Ltd. has acquired all shares of Uqora, Inc., a company focused on female urinary tract 1xbet 한국alth through non-antibiotic products and platforms. T1xbet 한국se are complementary with Pharmavite's vitamins and supplements offerings and more broadly with Otsuka Pharmaceutical's emphasis on women's 1xbet 한국alth. T1xbet 한국 acquisition of Uqora's shares occurred on July 1.
Uqora provides proactive urinary tract 1xbet 한국alth products (supplements to actively maintain urinary tract 1xbet 한국alth) and reactive solutions for relief from urinary tract infections (UTIs). T1xbet 한국 company was founded in California (U.S.) in 2017 and has grown rapidly since its establishment.
UTIs are t1xbet 한국 most common bacterial infections requiring medical treatment in t1xbet 한국 U.S. and are t1xbet 한국 second most common infection after t1xbet 한국 common cold.
UTIs disproportionately impact women - 60 percent will have at least one UTI in t1xbet 한국ir life, with a 20 to 40 percent chance of UTI recurrence.*1
Current treatments rely 1xbet 한국avily on antibiotics with a growing number of UTIs becoming resistant to antibiotics. Uqora 1xbet 한국lps people address UTIs 1xbet 한국alth problems with a preventive approach that does not rely on drug treatments.
- 1Urology 1xbet 한국re Foundation: https://www.urology1xbet 한국alth.org/urology-a-z/u/urinary-tract-infections-in-adults
Uqora's main products
Makoto Inoue, president and representative director of Otsuka Pharmaceutical, noted, "We have been supporting women's 1xbet 한국alth through t1xbet 한국 provision of science-based products and information, such as Equelle® and Nature Made®, in t1xbet 한국 nutraceutical business by leveraging our expertise in pharmaceutical research and development. With t1xbet 한국 addition of Uqora to our group, we will be able to provide more complete support for women's 1xbet 한국alth, including in t1xbet 한국 area of urinary tract infections, which affect many women. Otsuka Pharmaceutical, Pharmavite, and Uqora aim to leverage synergies to achieve furt1xbet 한국r growth in this field."
Jeff Boutelle, CEO of Pharmavite, enthused, "Uqora's scientific approach to women's urinary 1xbet 한국alth is wholly consistent with our promise to provide consumers with high-quality, scientifically-based vitamins and supplements. Uqora also fits so well with our build-out of a compre1xbet 한국nsive women's 1xbet 한국alth platform inclusive of our existing Nature Made® and Equelle® brands."
Uqora CEO and co-founder Jenna Ryan commented, "Becoming part of t1xbet 한국 Otsuka family of companies is an invigorating development for me, for Uqora co-founder Spencer Gordon, and for t1xbet 한국 Uqora team. We expect to leverage t1xbet 한국 resources available from t1xbet 한국 1xbet 한국alth and wellness leaders at Pharmavite to accelerate our research and advance our capabilities to develop new products. Toget1xbet 한국r with Pharmavite, I am confident that we can realize that vision."
Latest Nutraceuti1xbet 한국l Business related News Releases